TCA Phenol Peeling Composition Pain Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Trichloroacetic acid (TCA) peeling solutions cause significant burning pain during application, which can be a limiting factor for patients, as existing formulations do not effectively mitigate this pain, especially at concentrations between 10-25% TCA.

Innovation Solution

A combination of TCA concentrations between 10-25% with phenol concentrations between 0.5-10% is used to reduce the burning sensation during TCA peeling, with the phenol enhancing skin permeability and reducing phenol toxicity, thereby making the application less painful.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If TCA concentration is increased to improve peeling efficacy, then the treatment effectiveness is improved, but the burning pain increases

Engineering Contradiction:
Improvepeeling efficacyVSAvoidburning pain
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

Phenol is introduced as an intermediary substance that mediates between TCA and the skin tissue. The phenol acts as a pain-blocking agent that interferes with pain signal transmission while allowing TCA to perform its peeling function, thus resolving the contradiction between efficacy and pain

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention creates a composite peeling solution combining TCA and phenol in specific proportions. This composite formulation allows the synergistic effect where TCA provides the peeling action and phenol provides the analgesic effect, simultaneously achieving both high efficacy and pain reduction

Inventive Principle:
Principle #40Composite materials

2Object-affected harmful factors

If phenol concentration is increased to reduce burning pain, then the analgesic effect is improved, but the toxicity increases

Engineering Contradiction:
Improveburning painVSAvoidphenol toxicity
Core Design Contradiction:
Object-affected harmful factorsVSObject-generated harmful factors

Solution Approach 1:

The invention optimizes the phenol concentration parameter to a specific range (0.5-10%) where the analgesic effect is sufficient but toxicity is minimized. By precisely controlling this parameter, the solution achieves pain relief while maintaining safety

Inventive Principle:
Principle #35Parameter changes

3Reliability

If TCA concentration is increased to improve peeling depth, then the treatment effectiveness is improved, but the patient tolerance decreases

Engineering Contradiction:
Improvepeeling depthVSAvoidpatient tolerance
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

Phenol serves as a mediator that allows deeper peeling to be tolerated by blocking pain signals. This enables the use of higher TCA concentrations for deeper peeling while maintaining patient comfort through phenol's analgesic properties

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The addition of phenol to TCA peeling solutions in the specified concentration range significantly reduces the burning pain experienced during application, making the treatment more tolerable for patients, as confirmed by experimental tests.

Implementation Method 1

the action of TCA allows disrupting the skin permeability, and disrupted skin permeability allows a deeper and faster phenol penetration

Methodology Applied
Scientific EffectPermeation: Permeation

Implementation Method 2

Phenol peelings are used to coagulate the skin proteins, coagulating at the same time the noble structures of cells membranes

Methodology Applied
Scientific EffectCoagulation: Coagulation

Data Source

PatentEP2926867B1Peeling compositions comprising trichloroacetic acid (tca) and phenol for reducing the burning pain caused by the tca peeling
Publication Date: 2017.02.01 DEPREZ
  • EP2926867B1 patent drawing
  • EP2926867B1 patent drawing
  • EP2926867B1 patent drawing

AI summary

Peeling compositions comprising trichloroacetic acid (TCA) and phenol are described for reducing the burning pain caused by the TCA peeling. The efficacy of the pain control of this formulation has been controlled and confirmed in experimental tests.